Evidence map›Paper›PMID 32133986›Full record

ArticleActa crystallographica. Section D, Structural biology2020

ALIXE: a phase-combination tool for fragment-based molecular replacement.

Claudia Millán, Elisabet Jiménez, Antonia Schuster, Kay Diederichs, Isabel Usón

Abstract read
In one paragraph

Article in Acta crystallographica. Section D, Structural biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. SFCalculator: connecting deep generative models and crystallography.bioRxiv : the preprint server for biology · 2025
    Article
  2. ARCIMBOLDO at low resolution: Verification for coiled coils and globular proteins.Protein science : a publication of the Protein Society · 2024
    Article
  3. Modes and model building in SHELXE.Acta crystallographica. Section D, Structural biology · 2024
    Article
  4. Journal of applied crystallography · 2023
    Article
  5. Predicted models and CCP4.Acta crystallographica. Section D, Structural biology · 2023
    Article
  6. The CCP4 suite: integrative software for macromolecular crystallography.Acta crystallographica. Section D, Structural biology · 2023
    Article
  7. Fragment-BasedACS bio & med chem Au · 2023
    Article
  8. Article
  9. Verification: model-free phasing with enhanced predicted models in ARCIMBOLDO_SHREDDER.Acta crystallographica. Section D, Structural biology · 2022
    Article
  10. Article
  11. Helical ensembles outperform ideal helices in molecular replacement.Acta crystallographica. Section D, Structural biology · 2020
    Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Claudia MillánCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Barcelona Science Park, Helix Building, Baldiri Reixac 15, 08028 Barcelona, Spain.ORCID 0000-0002-9283-2220
Elisabet JiménezCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Barcelona Science Park, Helix Building, Baldiri Reixac 15, 08028 Barcelona, Spain.
Antonia SchusterDepartment of Biology, University of Konstanz, 78457 Konstanz, Germany.
Kay DiederichsDepartment of Biology, University of Konstanz, 78457 Konstanz, Germany.ORCID 0000-0001-5360-0905
Isabel UsónCrystallographic Methods, Institute of Molecular Biology of Barcelona (IBMB-CSIC), Barcelona Science Park, Helix Building, Baldiri Reixac 15, 08028 Barcelona, Spain.

Funding

Generalitat de Catalunya, Agència de Gestió d'Ajuts Universitaris i de Recerca 2017SGR-1192Ministerio de Economía, Industria y Competitividad, Gobierno de España BES-2015-071397Ministerio de Economía, Industria y Competitividad, Gobierno de España BIO2015-64216-PMinisterio de Economía, Industria y Competitividad, Gobierno de España MDM2014-0435-01Ministerio de Economía, Industria y Competitividad, Gobierno de España PGC2018-101370-B-100
6 · The paper itself

Abstract

Fragment-based molecular replacement exploits the use of very accurate yet incomplete search models. In the case of the ARCIMBOLDO programs, consistent phase sets produced from the placement and refinement of fragments with Phaser can be combined in order to increase their signal before proceeding to the step of density modification and autotracing with SHELXE. The program ALIXE compares multiple phase sets, evaluating mean phase differences to determine their common origin, and subsequently produces sets of combined phases that group consistent solutions. In this work, its use on different scenarios of very partial molecular-replacement solutions and its performance after the development of a much-optimized set of algorithms are described. The program is available both standalone and integrated within the ARCIMBOLDO programs. ALIXE has been analysed to identify its rate-limiting steps while exploring the best parameterization to improve its performance and make this software efficient enough to work on modest hardware. The algorithm has been parallelized and redesigned to meet the typical landscape of solutions. Analysis of pairwise correlation between the phase sets has also been explored to test whether this would provide additional insight. ALIXE can be used to exhaustively analyse all partial solutions produced or to complement those already selected for expansion, and also to reduce the number of redundant solutions, which is particularly relevant to the case of coiled coils, or to combine partial solutions from different programs. In each case parallelization and optimization to provide speedup makes its use amenable to typical hardware found in crystallography. ARCIMBOLDO_BORGES and ARCIMBOLDO_SHREDDER now call on ALIXE by default.

Indexed as

AlgorithmsSoftwareCrystallography, X-RayModels, MolecularMolecular StructureALIXEARCIMBOLDOcombinationfragment-based molecular replacementphasing

Identifiers

PMID32133986
PMCPMC7057212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.